Sunday, October 11, 2026

Gyrodyne Already 4% Up, Almost One Hour Before The NASDAQ Open

ViaNews Editorial Team

February 15, 2023

Gyrodyne Already 4% Up, Almost One Hour Before The NASDAQ Open

(VIANEWS) - The NASDAQ opens in less than one hour and Gyrodyne's pre-market value is already 4.95% up.

Gyrodyne's last close was $8.48, 42.97% below its 52-week high of $14.87.

The last session, NASDAQ finished with Gyrodyne (GYRO) sliding 0% to $8.48. NASDAQ jumped 0.57% to $11,960.15, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session.

About Gyrodyne

Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

Earnings Per Share

As for profitability, Gyrodyne has a trailing twelve months EPS of $-2.53.

Moving Average

Gyrodyne's worth is under its 50-day moving average of $8.74 and way under its 200-day moving average of $10.56.

Volume

Today's last reported volume for Gyrodyne is 182 which is 83.69% below its average volume of 1116.

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 2.74M for the twelve trailing months.

Yearly Top and Bottom Value

Gyrodyne's stock is valued at $8.48 at 08:42 EST, way below its 52-week high of $14.87 and above its 52-week low of $7.80.

More news about Gyrodyne (GYRO).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com